PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
25-Feb-2025 CMI Media Group unveils inaugural Media Vitals HCP Global research CMI Media Group
25-Feb-2025 Ottimo Pharma Strengthens Leadership Team with Senior Appointments Ottimo Pharma
25-Feb-2025 CNX Therapeutics appoints Peter Butterfield as Chief Operating Officer CNX Therapeutics
25-Feb-2025 PureTech to Present at the Leerink Partners Global Healthcare Conference PureTech
25-Feb-2025 Medtronic earns U.S. FDA approval for the world's first Adaptive deep brain stimulation system for people with Parkinson's Medtronic
25-Feb-2025 Labcorp Announces Clinical Availability of Liquid Biopsy Test to Guide Personalized Treatment Plans for Patients with Advanced Solid Tumors Labcorp
25-Feb-2025 National Alliance of Sickle Cell Centers and Terumo Blood and Cell Technologies Working Together to Improve Outcomes for Patients with Sickle Cell Disease Terumo Blood and Cell Technologies
25-Feb-2025 RISHI SUNAK JOINS PROSTATE CANCER RESEARCH AS AN AMBASSADOR Prostate Cancer Research
25-Feb-2025 Teledyne e2v announces new high-speed sensor with extended sensitivity in NIR wavelengths Teledyne e2v
25-Feb-2025 ONWARD Medical Announces Publication of One-Year Study Showing Benefit of Sustained Access to ARC-EX Therapy ONWARD Medical
25-Feb-2025 Sarclisa approved in Japan for patients with newly diagnosed multiple myeloma Sanofi
25-Feb-2025 OrganOx Completes $142 Million Equity Financing Led by HealthQuest Capital OrganOx
25-Feb-2025 Boehringer Ingelheim launches new trivalent poultry vaccine, includes protection against H5 avian influenza Boehringer Ingelheim
25-Feb-2025 Eckert & Ziegler Ensures Business Continuity After Cyber-Attack Eckert & Ziegler SE
25-Feb-2025 AMYRA Publishes Landmark Review Supporting New Gluten Digestion Approach for Celiac Disease AMYRA Biotech
25-Feb-2025 Formycon receives regulatory approval in the UK for FYB203 (aflibercept), a biosimilar to Eylea®, under the brand name AHZANTIVE® Formycon AG
24-Feb-2025 Cresset releases Flareā„¢ V10, the latest update to its agile ligand and structure-based drug design platform, Cresset
24-Feb-2025 Celltrion receives EC Approval for Avtozma® (CT-P47), a biosimilar to RoActemra® (tocilizumab) Celltrion
24-Feb-2025 Patients in the Midlands to Benefit from Revolutionary New Robotic Treatment for Enlarged Prostate Benign prostatic hyperplasia (BPH)
24-Feb-2025 Almirall surpassed guidance for 2024 - entering an era of sustained growth and further advancing its Medical Dermatology pipeline Almirall